Cerus (CERS) Other Non-Current Liabilities (2010 - 2026)
Cerus (CERS) reported Other Non-Current Liabilities of $5.4 million for Q1 2026, up 34.64% on a YoY basis from $4.0 million in Q1 2025, and up 0.5% sequentially from $5.4 million in Q4 2025.
Cerus (CERS) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Other Non-Current Liabilities data on file, last reported at $5.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities rose 34.64% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (up 34.64% YoY), and the FY2025 full-year result was $5.4 million, up 38.76% from the prior year.
- Other Non-Current Liabilities improved to $5.4 million in Q1 2026, from $5.4 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $5.4 million in Q1 2026 to a low of $2.4 million in Q1 2023.
- A 5-year average of $3.7 million and a median of $3.5 million in 2022 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities jumped 75.4% in 2022 and fell 26.4% in 2023, its largest moves.
- Tracing CERS's Other Non-Current Liabilities over 5 years: stood at $3.5 million in 2022, then fell by 7.52% to $3.2 million in 2023, then gained by 20.15% to $3.9 million in 2024, then jumped by 38.76% to $5.4 million in 2025, then climbed by 0.5% to $5.4 million in 2026.
- Business Quant data shows CERS's Other Non-Current Liabilities at $5.4 million in Q1 2026, $5.4 million in Q4 2025, and $5.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.24 Bn | 6.27 Bn |
| 2 | Stryker | 129.03 Bn | 126.15 Bn | 3.81 Bn |
| 3 | Medtronic | 108.43 Bn | 99.21 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.74 Bn | 67.28 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.78 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.42 Mn |
| Dec 31, 2025 | 5.40 Mn |
| Sep 30, 2025 | 5.22 Mn |
| Jun 30, 2025 | 4.37 Mn |
| Mar 31, 2025 | 4.03 Mn |
| Dec 31, 2024 | 3.89 Mn |
| Sep 30, 2024 | 3.80 Mn |
| Jun 30, 2024 | 3.62 Mn |
| Mar 31, 2024 | 3.43 Mn |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | 2.83 Mn |
| Jun 30, 2023 | 2.80 Mn |
| Mar 31, 2023 | 2.41 Mn |
| Dec 31, 2022 | 3.50 Mn |
| Sep 30, 2022 | 3.25 Mn |
| Jun 30, 2022 | 3.13 Mn |
| Mar 31, 2022 | 3.28 Mn |
| Dec 31, 2021 | 2.34 Mn |
| Sep 30, 2021 | 2.40 Mn |
| Jun 30, 2021 | 2.17 Mn |